scholarly journals Prohibition to add aroma and flavor to smoking products : what is the limit of the regulatory power of the brazilian health regulatory agency ?

2018 ◽  
Vol 8 (3) ◽  
Author(s):  
Joedson De Souza Delgado ◽  
Ivo Teixeira Gico Júnior
Keyword(s):  
Regulatory Agency

Arguments used by proponents and opponents in Brazil’s regulatory discussions of e-cigarettes and heated tobacco products

2021 ◽  
pp. tobaccocontrol-2021-056628
Author(s):  
Mônica Nunes-Rubinstein ◽  
Teresa Leão
Keyword(s):  
Public Health ◽  
Content Analysis ◽  
Cigarette Smoking ◽  
Health Risks ◽  
Regulatory Agency ◽  
Economic Consequences ◽  
The Other ◽  
Tobacco Products ◽  
The Right ◽  
Over Time

ObjectivesTo identify proponents and opponents of the commercialisation and marketing of e-cigarettes and heated tobacco products (HTPs), identify the arguments used on both sides and compare how the arguments have changed over time, we analysed three policy discussions occurring in 2009, 2018 and 2019.MethodsWe conducted a content analysis of one document and six videos from these discussions, provided on the Brazilian Health Regulatory Agency website, or upon request.ResultsThe arguments most used by tobacco companies were related to claims that the use of e-cigarettes and HTPs is less harmful than conventional tobacco. Unions that support its commercialisation also argued that lifting the ban would prevent smuggling and guarantee their quality. On the other side, universities, medical and anti-tobacco institutions argued that such devices may have health risks, including the risk of inducing cigarette smoking. In 2009, most arguments belonged to the ‘health’ theme, while in 2018 and 2019 economic arguments and those related to morals and ethics were frequently used.ConclusionsThose that supported the commercialisation and marketing of e-cigarettes and HTPs first focused on arguments of harm reduction, while 10 years later the right to access and potential economic consequences also became common. Public health agents and academics must gather evidence to effectively respond to these arguments and discuss these policies, and must prepare themselves to use and respond to arguments related to moral and economic themes.

scholarly journals Renal Vein Thrombosis and Pulmonary Embolism Secondary to Vaccine-induced Thrombotic Thrombocytopenia (VITT)

2021 ◽  
Author(s):  
Nikita Cliff-Patel ◽  
Lindsay Moncrieff ◽  
Veqas Ziauddin
Keyword(s):  
Pulmonary Embolism ◽  
General Hospital ◽  
Regulatory Agency ◽  
Renal Vein ◽  
District General Hospital ◽  
Renal Vein Thrombosis ◽  
The Other ◽  
Pulmonary Emboli ◽  
Vein Thrombosis ◽  
The Uk

The Medicines and Healthcare products Regulatory Agency (MHRA) of the UK has approved the use of three vaccines to combat COVID-19 (SARS-CoV-2). There have been rare reports of thrombosis after vaccination with the AstraZeneca vaccine. We present three cases of vaccine-induced thrombotic thrombocytopenia (VITT) in one UK district general hospital following administration of this vaccine. Two of the patients had asymptomatic pulmonary emboli, while the other is the first known case of both renal vein thrombosis and pulmonary embolism.

scholarly journals Restrição de Liquidez para Modelos de Seleção de Carteiras

2015 ◽  
Vol 13 (2) ◽  
pp. 288
Author(s):  
Gabriel Matos Pereira ◽  
Leonardo Riegel Sant'Anna ◽  
Tiago Pascoal Filomena ◽  
João Luiz Becker
Keyword(s):  
Stock Market ◽  
Portfolio Optimization ◽  
Financial Institutions ◽  
Portfolio Management ◽  
Regulatory Agency ◽  
Liquidity Constraint ◽  
Maximum Percentage ◽  
Monetary Value ◽  
High Influence

Liquidity is an important issue in portfolio management. In 2012, the Brazilian market regulatory agency (CVM) started to require all banks and brokerages to maintain liquidity control of their portfolios. This study presents a liquidity constraint which is endogenously incorporated to portfolio optimization to Brazilian Financial Institutions. The proposed constraint incorporates endogenously some practical issues such as: portfolio value, monetary volume traded, maximum percentage of monetary value, liquidation term date and liquidation level. This constrain is applied to the Brazilian Stock Market. The selected constraint parameters have high influence on the liquidity level of the portfolio.

scholarly journals 011 Methodological Issues Related To Mandatory Coverage Policies of the Brazilian Regulatory Agency (ANS) To Be Followed By Brazilian Private Health Plans (BPHP)

2013 ◽  
Vol 22 (Suppl 1) ◽  
pp. A15.1-A15
Author(s):  
M Cabanelas Pazos ◽  
S Alves da Silva ◽  
P Pereira de Souza ◽  
P Rascão Cardoso
Keyword(s):  
Regulatory Agency ◽  
Health Plans ◽  
Methodological Issues

Dilematika dan Tantangan Pengawasan Nuklir di Masa Pandemi COVID-19

2021 ◽  
Vol 1 (1) ◽  
pp. 7-11
Author(s):  
Khoirul Huda
Keyword(s):  
Regulatory Agency ◽  
Nuclear Energy ◽  
Health And Safety ◽  
Regulatory Control ◽  
Nuclear Radiation ◽  
Descriptive Method ◽  
Energy Regulatory

Dilematics and Challenges of Nuclear Regulatory Control During the Pandemic of Covid-19. Any activity using nuclear energy must be controlled by the Nuclear Energy Regulatory Agency (BAPETEN). The regulatory control is aimed at protecting the health and safety of working personnel, public and environment from the potential hazards arising from nuclear activities. In the implementation of regulatory control, it often needs to do activity involving a number of people, such as meeting to discuss regulation or to clarify some issues of licensing. In many cases, it needs also to do licensing verification and regulatory inspection to the nuclear/radiation facilities to ensure their safety conditions. However, since the outbreak of COVID-19, activities that involve many people such as meetings and visits must be reduced. This has created some regulatory dilemmas and challenges. Therefore, it is necessary to conduct a study to analyze these dilemmas/challenges to find their solutions. Present study using analytical descriptive method was performed to answer such problems. This paper presents results of the study in the form of analysis of the regulatory dilemmas/challenges, and recommends some solutions.¬

Sign in / Sign up

Export Citation Format

Share Document